Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03797183 · ClinicalTrials.gov registry record

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

A clinical trial of Healthy and Bronchopulmonary Dysplasia, sponsored by University of Colorado, Denver.

Recruiting
Registry status
90
Enrollment target
1
Study location

NCT03797183: Recruiting study of Healthy and Bronchopulmonary Dysplasia, sponsored by University of Colorado, Denver.

NCT03797183 is a study of Healthy and Bronchopulmonary Dysplasia that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 90 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03797183, a study of Healthy and Bronchopulmonary Dysplasia, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.

Primary Outcome

These images will be analyzed both visually for qualitative abnormalities and through quantitative pixel analysis that can provide information regarding lung volume, blood volume, and changes in either based on respiratory cycle, cardiac cycle, or intervention. Areas of low ventilation (atelectasis and consolidation) will be identified.

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2019-05-03
Est. Completion 2026-11
University of Colorado, Denver

1,283 total trials

What NCT03797183 shows while recruiting

NCT03797183 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower).

The record links to 6 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT03797183 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT03797183 about?

NCT03797183 is a clinical study titled "Genesis Electrical Impedance Tomography (EIT): A Preliminary Study". The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is...

What is the current status of trial NCT03797183?

This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2019-05-03. Estimated completion is 2026-11.

What conditions does trial NCT03797183 study?

This clinical trial studies the following conditions: Healthy, Bronchopulmonary Dysplasia, Neuromuscular Diseases, Premature Infant, Chronic Respiratory Disease.

Who is sponsoring clinical trial NCT03797183?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03797183 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03797183's enrollment target sits among peer trials

90 252nd of 1090 higher than 833 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03797183, the US trial registry maintained by the National Library of Medicine. NCT03797183 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.